Targeted Therapy for BRCA2 Deficient Tumors.
Goetz
Matthew
M
Department of Oncology and Laboratory Medicine and Pathology, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA.
Couch
Fergus J
FJ
D017209:Apoptosis / Q000187:drug effects*; D024682:BRCA2 Protein / Q000172:deficiency* / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016368:Frameshift Mutation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
D024682:BRCA2 Protein; D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors